Number of Eye Injections for Retinal Vein Occlusion and Follow-up Protocol

How many injections does a patient with retinal vein occlusion need? Dr. Mahmoud Hassan explains how to determine the injection schedule based on the eye's response and central vision stability.

Number of Eye Injections for Retinal Vein Occlusion and Follow-up Protocol

Retinal Vein Occlusion Eye Injections and Follow-up Protocol: A Journey to Vision Restoration

Retinal vein occlusion (RVO), whether central (CRVO) or branch (BRVO), is a serious medical condition requiring swift and precise intervention to protect vision from deterioration. Among the most prominent modern and effective treatments for this condition, intravitreal injection stands out as a cornerstone in restoring visual function and reducing complications. However, a significant question arises among patients: How many eye injections does a patient need to treat retinal vein occlusion? And what is the optimal follow-up protocol to ensure the best results? Dr. Mahmoud Hassan, a retina and vitreous surgeon, answers these important questions.

Understanding the Mechanism of Intravitreal Injection Treatment

In cases of retinal vein occlusion, fluid leaks from damaged blood vessels in the retina, leading to swelling in the macula (the central part of vision), known as macular edema. This edema is the primary cause of central vision deterioration and loss of fine detail. Medications injected into the eye, such as Eylea and Vabysmo, work by inhibiting vascular endothelial growth factor (VEGF), proteins that cause increased blood vessel permeability and the formation of abnormal new blood vessels. By reducing VEGF levels, these injections help decrease leakage and swelling in the retina, contributing to improved and stabilized vision.

Determining the Number of Injections: Eye Response is Key

There is no fixed and predetermined number of eye injections that suits all patients with retinal vein occlusion. The decision regarding the number and frequency of doses depends primarily on the patient's eye response to treatment, the extent of retinal improvement, and the stability of central vision. The treatment protocol usually begins with a series of initial injections, often monthly, to effectively control inflammation and swelling. During this period, Dr. Mahmoud Hassan, a key contributor to Al Mashreq Eye Center in Cairo, conducts a thorough evaluation of the patient's condition.

Regular Vision and Retinal Assessment

Regular assessment includes:

Adjusting the Injection Schedule Based on Results

Based on the results of these examinations, the injection schedule is adjusted. If the examinations show significant improvement in vision and a marked reduction in retinal swelling, the interval between injections may be extended. For example, the patient may go from monthly injections to injections every two months, then every three months, and so on. The goal is to reach the fewest possible injections while maintaining visual stability and preventing recurrence of edema. In some cases, the patient may need a few injections, while others may require long-term treatment that can extend for years.

Follow-Up Protocol After Injections: Ensuring Long-Term Stability

The role of treatment does not end once initial improvement is achieved; accurate and continuous follow-up is key to long-term success. Dr. Mahmoud Hassan at Al Mashreq Eye Center establishes a strict follow-up protocol for patients with retinal vein occlusion to ensure early detection of any signs of disease recurrence or complications.

Importance of Regular Follow-Up

Regular follow-up includes:

When Do We Need Re-Injections?

The patient may need re-injections if follow-up examinations show recurrent macular edema or deterioration in visual acuity. In this case, the condition is re-evaluated to determine if injection is necessary and to identify the appropriate medication. In some cases, injection therapy may need to be combined with other treatments, such as retinal laser, especially in cases of retinal vein occlusion accompanied by hypoxia or neovascularization. Treating macular edema associated with vein occlusion and Anti-VEGF injections is a field that requires specialized expertise to ensure the best outcomes.

Conclusion: A Treatment Journey Requiring Patience and Commitment

Determining the number of eye injections for retinal vein occlusion and the follow-up protocol is a highly dynamic and personalized process. Success depends on close cooperation between the patient and the doctor, adherence to medical appointments, and accurate monitoring of the eye's response. At Al Mashreq Eye Center, we pride ourselves on providing the latest technologies and integrated care for retina patients, under the supervision of a select group of specialized doctors. If you are experiencing symptoms of retinal vein occlusion, do not hesitate to seek specialized medical advice.

You can follow valuable medical information and tips through .

For reservations and inquiries: 01002310813

Articles you might like to read

Frequently Asked Questions

ما هو انسداد الوريد الشبكي وما هي أنواعه الرئيسية؟

انسداد الوريد الشبكي هو حالة طبية خطيرة تحدث عند انسداد الأوعية الدموية في الشبكية، مما يؤدي إلى تسرب السوائل وتورم في منطقة الماكولا. ينقسم إلى نوعين رئيسيين: انسداد الوريد الشبكي المركزي (CRVO) وانسداد الوريد الشبكي الفرعي (BRVO).

كيف تعمل حقن العين داخل الجسم الزجاجي في علاج انسداد الوريد الشبكي؟

تعمل حقن العين داخل الجسم الزجاجي، مثل إيليا وفابيسمو، على تثبيط عوامل النمو الوعائي البطاني (VEGF). هذه البروتينات تسبب زيادة نفاذية الأوعية الدموية وتكوين أوعية دموية غير طبيعية. بتقليل مستويات VEGF، تساعد هذه الحقن على تقليل التسرب والتورم في الشبكية، مما يحسن الرؤية.

ما الذي يحدد عدد مرات حقن العين المطلوبة لعلاج انسداد الوريد الشبكي؟

لا يوجد عدد ثابت من الحقن. يعتمد عدد الجرعات وتكرارها بشكل أساسي على استجابة عين المريض للعلاج، ومدى تحسن حالة الشبكية، واستقرار الرؤية المركزية. يتم تعديل جدول الحقن بناءً على التقييم الدوري للرؤية وفحوصات الشبكية مثل التصوير المقطعي (OCT).

ما هي أهمية بروتوكول المتابعة بعد الحقن لعلاج انسداد الوريد الشبكي؟

المتابعة الدقيقة والمستمرة ضرورية لضمان الاستقرار طويل الأمد واكتشاف أي علامات لعودة المرض أو ظهور مضاعفات مبكرًا. تشمل المتابعة زيارات دورية للطبيب، ومراقبة علامات التحذير، والتحكم في عوامل الخطر مثل ارتفاع ضغط الدم والسكري.

متى قد يحتاج المريض إلى إعادة الحقن بعد العلاج الأولي؟

قد يحتاج المريض إلى إعادة الحقن إذا أظهرت فحوصات المتابعة عودة ظهور ارتشاح الماكولا أو تدهور في حدة الإبصار. في هذه الحالات، يتم تقييم الحالة لتحديد ما إذا كان الحقن ضروريًا ونوع الدواء المناسب، وقد يتم دمج العلاج مع علاجات أخرى مثل ليزر الشبكية.


https://drmahmoud-hassaan.com/en/articles/injection-frequency-for-retinal-occlusion